Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
The report details the trend, potential and market size of MEK Inhibitors market, and analyzes the current situation and prospects of the market from both qualitative and quantitative aspects, which can be roughly divided into three parts.
The first part (Chapter1-7) mainly covers the qualitative analysis of MEK Inhibitorsmarket, defines the market attractiveness level of MEK Inhibitors market through Porter's Five Forces Analysis, and summarizes the different factors in the overall environment through PEST analysis. Understand the distribution of industrial chain value in each link of industrial chain through the analysis of industrial chain structure. Thus estimate the market space of each link.
The second part (Chapter8-12), based on the segmentation of MEK Inhibitors industry, describes the types of MEK Inhibitors market, the applications of major players and the market size, and deeply analyzes the current situation of the global MEK Inhibitors market and the development prospects and opportunities of MEK Inhibitors industry.
The third part (Chapter14-15) includes the market positions of the major players and information on the market participants, which will help you gain a comprehensive understanding of the current competitive situation and potential growth opportunities in the market.
As COVID-19 continues to impact the global economy in 2022, the report also considers the short - and long-term impacts of COVID-19 on the global MEK Inhibitors market in Chapter 13.
By Player:
AstraZeneca Plc
Pfizer Inc
Novartis AG
Ono Pharmaceutical Co Ltd
F Hoffmann-La Roche Ltd
By Type:
MEKINIST
COTELLIC
MEKTOVI
By End-User:
NSCLC
Cancer
By Geography:
-
United States
-
Europe
-
China
-
Japan
-
India
-
South Korea
TABLE OF CONTENT
1 Introduction
-
1.1 Market Definition
-
1.2 Market Segment Analysis
-
1.3 Market Size 2022
-
1.4 MEK Inhibitors Market Outlook: Forecast for 2022 - 2028
-
1.5 Pricing Analysis
2 Executive Summary
3 MEK Inhibitors Market Lineage Outlook
-
3.1 Parent Market Outlook
-
3.2 Related/Ancillary Market Outlook
-
3.3 Penetration & Growth Prospect Mapping, 2022
4 Market Analysis Tools: Porter's Five Forces
-
4.1 Supplier Power
-
4.2 Buyer Power
-
4.3 Substitution Threat
-
4.4 Threat of New Entrants
-
4.5 Competitive Rivalry
5 MEK Inhibitors Industry Analysis - PEST (Political & Legal, Economic, Social, and Technological)
-
5.1 Political/Legal Landscape
-
5.2 Economic Landscape
-
5.3 Social Landscape
-
5.4 Technology Landscape
6 MEK Inhibitors Market - Value Chain Analysis
-
6.1 Industry's Value Chain Analysis
-
6.2 Product Life Cycle
-
6.3 User Perspective Analysis
7 Region and Country-wise MEK Inhibitors Market Analysis and Outlook to 2022
-
7.1 Global MEK Inhibitors Consumption (2017-2022)
-
7.2 United States MEK Inhibitors Consumption (2017-2022)
-
7.3 Europe MEK Inhibitors Consumption (2017-2022)
-
7.4 China MEK Inhibitors Consumption (2017-2022)
-
7.5 Japan MEK Inhibitors Consumption (2017-2022)
-
7.6 India MEK Inhibitors Consumption (2017-2022)
-
7.7 South Korea MEK Inhibitors Consumption (2017-2022)
8 Region and Country-wise MEK Inhibitors Market Analysis and Outlook to 2028
-
8.1 Global MEK Inhibitors Consumption Forecast (2022-2028)
-
8.2 United States MEK Inhibitors Consumption Forecast (2022-2028)
-
8.3 Europe MEK Inhibitors Consumption Forecast (2022-2028)
-
8.4 China MEK Inhibitors Consumption Forecast (2022-2028)
-
8.5 Japan MEK Inhibitors Consumption Forecast (2022-2028)
-
8.6 India MEK Inhibitors Consumption Forecast (2022-2028)
-
8.7 South Korea MEK Inhibitors Consumption Forecast (2022-2028)
9 Global MEK Inhibitors Market Outlook by Types and Applications to 2022
-
9.1 Global MEK Inhibitors Consumption and Growth Rate by Type (2017-2022)
-
9.1.1 Global MEKINIST Consumption and Growth Rate (2017-2022)
-
9.1.2 Global COTELLIC Consumption and Growth Rate (2017-2022)
-
9.1.3 Global MEKTOVI Consumption and Growth Rate (2017-2022)
-
9.2 Global MEK Inhibitors Consumption and Growth Rate by Application (2017-2022)
-
9.2.1 Global NSCLC Consumption and Growth Rate (2017-2022)
-
9.2.2 Global Cancer Consumption and Growth Rate (2017-2022)
10 Global MEK Inhibitors Market Outlook by Types and Applications to 2028
-
10.1 Global MEK Inhibitors Consumption Forecast and Growth Rate by Type (2022-2028)
-
10.1.1 Global MEKINIST Consumption Forecast and Growth Rate (2022-2028)
-
10.1.2 Global COTELLIC Consumption Forecast and Growth Rate (2022-2028)
-
10.1.3 Global MEKTOVI Consumption Forecast and Growth Rate (2022-2028)
-
10.2 Global MEK Inhibitors Consumption Forecast and Growth Rate by Application (2022-2028)
-
10.2.1 Global NSCLC Consumption Forecast and Growth Rate (2022-2028)
-
10.2.2 Global Cancer Consumption Forecast and Growth Rate (2022-2028)
11 Global MEK Inhibitors Import and Export Analysis (Top 5 Countries)
-
11.1 Global MEK Inhibitors Import by Region (Top 5 Countries) (2017-2028)
-
11.2 Global MEK Inhibitors Export by Region (Top 5 Countries) (2017-2028)
12 Coronavirus Disease (COVID-19) Impact
-
12.1 Industry Impact Analysis
-
12.2 MEK Inhibitors Market Outlook to 2028 - COVID-19 Affected Forecasts
13 Competition Matrix
-
13.1 Target Markets
-
13.2 Comprehensive Analysis of Products in Competitive Markets
14 Global MEK Inhibitors Market Competitive Analysis
-
14.1 AstraZeneca Plc
-
14.1.1 AstraZeneca Plc Company Details
-
14.1.2 AstraZeneca Plc MEK Inhibitors Sales, Price, Value and Gross Profit (2017-2022)
-
14.1.3 AstraZeneca Plc MEK Inhibitors Product and Service
-
14.2 Pfizer Inc
-
14.2.1 Pfizer Inc Company Details
-
14.2.2 Pfizer Inc MEK Inhibitors Sales, Price, Value and Gross Profit (2017-2022)
-
14.2.3 Pfizer Inc MEK Inhibitors Product and Service
-
14.3 Novartis AG
-
14.3.1 Novartis AG Company Details
-
14.3.2 Novartis AG MEK Inhibitors Sales, Price, Value and Gross Profit (2017-2022)
-
14.3.3 Novartis AG MEK Inhibitors Product and Service
-
14.4 Ono Pharmaceutical Co Ltd
-
14.4.1 Ono Pharmaceutical Co Ltd Company Details
-
14.4.2 Ono Pharmaceutical Co Ltd MEK Inhibitors Sales, Price, Value and Gross Profit (2017-2022)
-
14.4.3 Ono Pharmaceutical Co Ltd MEK Inhibitors Product and Service
-
14.5 F Hoffmann-La Roche Ltd
-
14.5.1 F Hoffmann-La Roche Ltd Company Details
-
14.5.2 F Hoffmann-La Roche Ltd MEK Inhibitors Sales, Price, Value and Gross Profit (2017-2022)
-
14.5.3 F Hoffmann-La Roche Ltd MEK Inhibitors Product and Service
15 Appendix
TABLE OF CHARTS
-
Table Definition of MEK Inhibitors
-
Figure MEK Inhibitors Picture
-
Table Global MEK Inhibitors Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global MEK Inhibitors Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global MEK Inhibitors Market: Year-over-year Growth 2022 - 2028 (%)
-
Table Parent Market Analysis
-
Figure Parent Market Price
-
Table Related/Ancillary Market Outlook Analysis
-
Table Supplier Power Analysis
-
Table Buyer Power Analysis
-
Table Substitution Threat Analysis
-
Table Threat of New Entrants Analysis
-
Table Competitive Rivalry Analysis
-
Figure Global MEK Inhibitors Consumption by Country (2017-2022)
-
Figure United States MEK Inhibitors Consumption and Growth Rate (2017-2022)
-
Table Europe MEK Inhibitors Consumption and Growth Rate (2017-2022)
-
Figure China MEK Inhibitors Consumption and Growth Rate (2017-2022)
-
Figure Japan MEK Inhibitors Consumption and Growth Rate (2017-2022)
-
Figure India MEK Inhibitors Consumption and Growth Rate (2017-2022)
-
Figure South Korea MEK Inhibitors Consumption and Growth Rate (2017-2022)
-
Figure Global MEK Inhibitors Consumption Forecast by Country (2022-2028)
-
Figure United States MEK Inhibitors Consumption Forecast and Growth Rate (2022-2028)
-
Table Europe MEK Inhibitors Consumption Forecast and Growth Rate (2022-2028)
-
Figure China MEK Inhibitors Consumption Forecast and Growth Rate (2022-2028)
-
Figure Japan MEK Inhibitors Consumption Forecast and Growth Rate (2022-2028)
-
Figure India MEK Inhibitors Consumption Forecast and Growth Rate (2022-2028)
-
Figure South Korea MEK Inhibitors Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global MEKINIST Consumption and Growth Rate (2017-2022)
-
Figure Global COTELLIC Consumption and Growth Rate (2017-2022)
-
Figure Global MEKTOVI Consumption and Growth Rate (2017-2022)
-
Figure Global NSCLC Consumption and Growth Rate (2017-2022)
-
Figure Global Cancer Consumption and Growth Rate (2017-2022)
-
Figure Global MEKINIST Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global COTELLIC Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global MEKTOVI Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global NSCLC Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Cancer Consumption Forecast and Growth Rate (2022-2028)
-
Table Global MEK Inhibitors Import by Region (Top 5 Countries) (2017-2028)
-
Table Global MEK Inhibitors Export by Region (Top 5 Countries) (2017-2028)
-
Table AstraZeneca Plc (Foundation Year, Company Profile and etc.)
-
Table AstraZeneca Plc MEK Inhibitors Sales, Price, Value and Gross Profit (2017-2022)
-
Table AstraZeneca Plc MEK Inhibitors Product and Service
-
Table Pfizer Inc (Foundation Year, Company Profile and etc.)
-
Table Pfizer Inc MEK Inhibitors Sales, Price, Value and Gross Profit (2017-2022)
-
Table Pfizer Inc MEK Inhibitors Product and Service
-
Table Novartis AG (Foundation Year, Company Profile and etc.)
-
Table Novartis AG MEK Inhibitors Sales, Price, Value and Gross Profit (2017-2022)
-
Table Novartis AG MEK Inhibitors Product and Service
-
Table Ono Pharmaceutical Co Ltd (Foundation Year, Company Profile and etc.)
-
Table Ono Pharmaceutical Co Ltd MEK Inhibitors Sales, Price, Value and Gross Profit (2017-2022)
-
Table Ono Pharmaceutical Co Ltd MEK Inhibitors Product and Service
-
Table F Hoffmann-La Roche Ltd (Foundation Year, Company Profile and etc.)
-
Table F Hoffmann-La Roche Ltd MEK Inhibitors Sales, Price, Value and Gross Profit (2017-2022)
-
Table F Hoffmann-La Roche Ltd MEK Inhibitors Product and Service
-
